CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.790
-0.160 (-4.05%)
Nov 7, 2024, 4:00 PM EST - Market closed
CollPlant Biotechnologies Employees
CollPlant Biotechnologies had 75 employees as of December 31, 2023. The number of employees increased by 2 or 2.74% compared to the previous year.
Employees
75
Change (1Y)
2
Growth (1Y)
2.74%
Revenue / Employee
$9,187
Profits / Employee
-$232,947
Market Cap
43.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
LakeShore Biopharma | 758 |
SHL Telemedicine | 583 |
Achilles Therapeutics | 215 |
Exagen | 179 |
ProPhase Labs | 113 |
Carisma Therapeutics | 107 |
IceCure Medical | 77 |
DURECT | 58 |
CLGN News
- 2 months ago - CollPlant Biotechnologies Ltd. (CLGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 2 months ago - CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants - Business Wire
- 3 months ago - COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 SECOND QUARTER FINANCIAL STATEMENTS AND CONFERENCE CALL INFORMATION - PRNewsWire
- 3 months ago - CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report - PRNewsWire
- 5 months ago - CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data - PRNewsWire
- 5 months ago - CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update - PRNewsWire